FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称TADOCIZUMAB
异名/同义词C4G1
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.IIB.BETA.3) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL C4G1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C4G1 .KAPPA.-CHAIN
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.IIB.BETA.3) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL C4G1 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C4G1 .KAPPA.-CHAIN
TADOCIZUMAB
TADOCIZUMAB [INN]
TADOCIZUMAB [USAN]
YM337
YM-337
CAS登记号339086-80-5
物质唯一标识(Unique Ingredient Identifier)R34T642CGV
分子式8651
国际化合物标识(International Chemical Identifier,InChI)QQ-06
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 /
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System